Transgenic Group Inc. (TYO:2342)
Japan · Delayed Price · Currency is JPY 239.00
-3.00 (-1.24%)
Oct 6, 2026, 3:30 PM JST
Transgenic Group Market Cap
Transgenic Group has a market cap or net worth of 3.98 billion as of October 6, 2026. Its market cap has increased by 11.68% in one year.
Market Cap
3.98B
Enterprise Value
4.38B
Revenue
13.64B
Ranking
n/a
PE Ratio
120.61
Stock Price
239.00
ChartMarket Cap Chart
Since July 2, 2003, Transgenic Group's market cap has decreased from 9.78B to 3.98B, a decrease of -59.29%. That is a compound annual growth rate of -3.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 3.98B | -21.64% |
| Dec 30, 2025 | 5.08B | 73.30% |
| Dec 30, 2024 | 2.93B | -33.27% |
| Dec 29, 2023 | 4.39B | -20.08% |
| Dec 30, 2022 | 5.50B | -27.38% |
| Dec 30, 2021 | 7.57B | -5.27% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Chordia Therapeutics | 4.79B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |
| Kohjin Bio | 4.21B |